These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 34184949)

  • 21. Customizing poly(lactic-co-glycolic acid) particles for biomedical applications.
    Swider E; Koshkina O; Tel J; Cruz LJ; de Vries IJM; Srinivas M
    Acta Biomater; 2018 Jun; 73():38-51. PubMed ID: 29653217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation.
    Bittner B; Mäder K; Kroll C; Borchert HH; Kissel T
    J Control Release; 1999 May; 59(1):23-32. PubMed ID: 10210719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodegradable and complexed microspheres used for sustained delivery and activity protection of SOD.
    Wang Y; Gao JQ; Zheng CH; Xu DH; Liang WQ
    J Biomed Mater Res B Appl Biomater; 2006 Oct; 79(1):74-8. PubMed ID: 16506185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and characterization of poly(D,L-lactic-co-glycolic Acid) microspheres containing flurbiprofen sodium.
    Samati Y; Yüksel N; Tarimci N
    Drug Deliv; 2006; 13(2):105-11. PubMed ID: 16423798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics.
    Ding D; Zhu Q
    Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():1041-1060. PubMed ID: 30184728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of a novel approach to prepare biodegradable polylactic-co-glycolic acid microspheres: surface liquid spraying.
    Tang H; Xu N; Meng J; Wang C; Nie SF; Pan WS
    Yakugaku Zasshi; 2007 Nov; 127(11):1851-62. PubMed ID: 17978561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation.
    Yang Z; Birkenhauer P; Julmy F; Chickering D; Ranieri JP; Merkle HP; Lüscher TF; Gander B
    J Control Release; 1999 Aug; 60(2-3):269-77. PubMed ID: 10425332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and performance of exendin-4-loaded chitosan-PLGA microspheres for enhancing implant osseointegration in type 2 diabetic rats.
    Shi S; Song S; Liu X; Zhao G; Ding F; Zhao W; Zhang S; Song Y; Ma W
    Drug Deliv; 2022 Dec; 29(1):548-560. PubMed ID: 35156499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Encapsulation and release of doxycycline from electrospray-generated PLGA microspheres: Effect of polymer end groups.
    Wang J; Helder L; Shao J; Jansen JA; Yang M; Yang F
    Int J Pharm; 2019 Jun; 564():1-9. PubMed ID: 30978487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres.
    Beig A; Feng L; Walker J; Ackermann R; Hong JKY; Li T; Wang Y; Qin B; Schwendeman SP
    Mol Pharm; 2020 Nov; 17(11):4141-4151. PubMed ID: 32876463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly(lactide-co-glycolide) microspheres with good biocompatibility.
    An R; Tang W; Zhao Z; Liu W; Kan L
    Acta Bioeng Biomech; 2023 Dec; 25(4):111-120. PubMed ID: 39072465
    [No Abstract]   [Full Text] [Related]  

  • 32. Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug.
    Ryu S; Park S; Lee HY; Lee H; Cho CW; Baek JS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface studies of coated polymer microspheres and protein release from tissue-engineered scaffolds.
    Meese TM; Hu Y; Nowak RW; Marra KG
    J Biomater Sci Polym Ed; 2002; 13(2):141-51. PubMed ID: 12022746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microfluidics for producing poly (lactic-co-glycolic acid)-based pharmaceutical nanoparticles.
    Li X; Jiang X
    Adv Drug Deliv Rev; 2018 Mar; 128():101-114. PubMed ID: 29277543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug micro-carriers with a hyaluronic acid corona toward a diffusion-limited aggregation within the vitreous body.
    Mayol L; Silvestri T; Fusco S; Borzacchiello A; De Rosa G; Biondi M
    Carbohydr Polym; 2019 Sep; 220():185-190. PubMed ID: 31196539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Branched PLGA derivatives with tailored drug delivery properties.
    Snejdrova E; Podzimek S; Martiska J; Holas O; Dittrich M
    Acta Pharm; 2020 Mar; 70(1):63-75. PubMed ID: 31677370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres.
    Uchida T; Yagi A; Oda Y; Nakada Y; Goto S
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):235-6. PubMed ID: 8582042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dry fabrication of poly(dl-lactide-co-glycolide) microspheres incorporating a medium molecular drug by a ball mill method.
    Matsumoto A; Murakami M
    Drug Discov Ther; 2021 Mar; 15(1):20-27. PubMed ID: 33627576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microfluidic-based fabrication and characterization of drug-loaded PLGA magnetic microspheres with tunable shell thickness.
    He C; Zeng W; Su Y; Sun R; Xiao Y; Zhang B; Liu W; Wang R; Zhang X; Chen C
    Drug Deliv; 2021 Dec; 28(1):692-699. PubMed ID: 33818236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.